Q2 2024

Filed Aug 6, 2024 · 10-Q · 37 days after period end · 0000877860-24-000065

Q2 2024 · 10-Q

Revenue

$13.39M

+13.5% vs Q2 2023

Net Income

$35.26M

−11.4% vs Q2 2023

EPS Diluted

$0.81

−12.0% vs Q2 2023

Operating Cash Flowderived$60,739,000+20.3%

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$13.39M	$11.79M	$11.99M	$0.00
Net Income	$35.26M	$39.78M	$21.67M	$39.18M
EPS Diluted	$0.81	$0.92	$0.47	$0.85

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR